Transbronchial lung cryo-rebiopsy for progressive interstitial lung disease
Cryo-rebiopsy in patients with progressive ILD is as safe as the initial TBLC and provides opportunities for pathology-based treatment adjustment for precision medicine.
Authors
- Tamiko Takemura (ORCID: https://orcid.org/0000-0001-6937-1991)
- Eri Hagiwara (ORCID: https://orcid.org/0000-0003-0079-7462)
- Takashi Ogura (ORCID: https://orcid.org/0000-0002-7445-270X)
- Tomoe Sawazumi (ORCID: https://orcid.org/0000-0002-2427-2399)
- Tae Iwasawa (ORCID: https://orcid.org/0000-0003-4535-653X)
- Takashi Niwa (ORCID: https://orcid.org/0009-0000-3567-3481)
- Tomohisa Baba (ORCID: https://orcid.org/0000-0003-4294-634X)
- Chieri Yamada
Institutions
- Kanagawa Cardiovascular and Respiratory Center (JP)
Publication Details
- Journal
- Respiratory Investigation
- Published
- 2025-08-05
- DOI
- https://doi.org/10.1016/j.resinv.2025.07.015
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00